Free Trial

Elevation Oncology (ELEV) Institutional Ownership

→ Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad)
Free ELEV Stock Alerts
$3.76
+0.15 (+4.16%)
(As of 12:44 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)

Current
Institutional Ownership
Percentage
83.70%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$32.56M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$7.53M
Get ELEV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELEV Institutional Buying and Selling by Quarter

Elevation Oncology Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 Artal Group S.A.1,513,015$7.76M0.2%N/A2.769%
5/17/2024 Ikarian Capital LLC148,089$760K0.1%-87.4%0.271%
5/15/2024 venBio Partners LLC2,696,133$13.83M4.9%-7.5%4.934%
5/15/2024 Darwin Global Management Ltd.2,332,928$11.97M1.6%N/A4.270%
5/15/2024 Affinity Asset Advisors LLC1,268,825$6.51M0.8%N/A2.322%
5/10/2024 Vanguard Group Inc.1,532,045$7.86M0.0%+30.8%2.804%
5/7/2024 SG Americas Securities LLC12,244$63K0.0%N/A0.022%
11/15/2023 Armistice Capital LLC750,000$497K0.0%-68.7%1.768%
8/15/2023 Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124%
8/15/2023 Caxton Corp21,725$33K0.1%-68.2%0.051%
8/11/2023 Velan Capital Investment Management LP497,299$756K0.7%N/A1.173%
8/11/2023 ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160%
5/15/2023 Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685%
5/1/2023Virtu Financial LLC27,286$52K0.0%N/A0.115%
2/15/2023 Tang Capital Management LLC479,854$456K0.1%N/A2.059%
2/13/2023 BML Capital Management LLC39,963$38K0.0%N/A0.172%
11/14/2022 Annandale Capital LLC30,000$34K0.0%N/A0.129%
11/14/2022 Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377%
8/16/2022 venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013%
8/10/2022 Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644%
4/26/2022 Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168%
4/25/2022 Bailard Inc.23,500$59K0.0%N/A0.101%
2/18/2022 TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389%
2/15/2022 Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067%
2/14/2022 Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758%
2/14/2022 Sio Capital Management LLC250,000$1.51M0.5%N/A1.076%
1/19/2022 Marquette Asset Management LLC9,006$54K0.0%N/A0.039%
11/16/2021 Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078%
11/16/2021 Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254%
11/16/2021 Caxton Corp48,183$375K0.3%+21.7%0.207%
11/9/2021 BlackRock Inc.23,837$186K0.0%N/A0.103%
8/17/2021 Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066%
8/17/2021 Woodline Partners LP112,431$1.53M0.0%N/A0.493%
8/17/2021 Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085%
8/17/2021 Sphera Funds Management LTD.30,000$407K0.0%N/A0.131%
8/17/2021 Millennium Management LLC123,062$1.67M0.0%N/A0.539%
8/17/2021 BVF Inc. IL1,590,291$21.58M0.8%N/A6.968%
8/17/2021 Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878%
8/17/2021 Caas Capital Management LP60,000$814K0.0%N/A0.263%
8/17/2021 Caxton Corp39,586$537K0.4%N/A0.173%
The Overlooked Retirement Asset You Probably Don’t Own (Ad)

4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.

Click here to access the Crypto Retirement Blueprint now.
8/16/2021 LMR Partners LLP31,300$425K0.0%N/A0.137%
8/16/2021 Point72 Asset Management L.P.50,000$679K0.0%N/A0.219%
8/16/2021 venBio Partners LLC2,608,167$35.39M4.2%N/A11.428%
8/16/2021 Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548%
8/16/2021 Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113%
8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159%
8/16/2021 Maven Securities LTD16,000$204K0.0%N/A0.070%
8/16/2021 Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274%
8/13/2021 Northern Trust Corp4,803$65K0.0%N/A0.021%
8/13/2021 Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106%
8/13/2021 Vanguard Group Inc.60,000$814K0.0%N/A0.263%
8/12/2021 Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613%
8/11/2021 Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438%
(Data available from 1/1/2016 forward)

ELEV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELEV shares?

During the previous two years, 19 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were venBio Partners LLC ($13.83M), Darwin Global Management Ltd. ($11.97M), Vanguard Group Inc. ($7.86M), Artal Group S.A. ($7.76M), Affinity Asset Advisors LLC ($6.51M), ExodusPoint Capital Management LP ($2.28M), and Cormorant Asset Management LP ($2.21M).Learn more on ELEV's institutional investors.

What percentage of Elevation Oncology stock is owned by institutional investors?

83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings.

Which institutional investors have been buying Elevation Oncology stock?

Of the 14 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Darwin Global Management Ltd. ($2.33M), Artal Group S.A. ($1.51M), ExodusPoint Capital Management LP ($1.50M), Affinity Asset Advisors LLC ($1.27M), Sphera Funds Management LTD. ($900K), Sio Capital Management LLC ($516.88K), and Velan Capital Investment Management LP ($497.30K).

How much institutional buying is happening at Elevation Oncology?

Institutional investors have bought a total of 9,614,275 shares in the last 24 months. This purchase volume represents approximately $34.31M in transactions.

Which Elevation Oncology major shareholders have been selling company stock?

The following institutional investors have sold Elevation Oncology stock in the last 24 months: Armistice Capital LLC ($1.65M), Ikarian Capital LLC ($1.02M), venBio Partners LLC ($959.95K), Caxton Corp ($46.60K), and Cormorant Asset Management LP ($31.14K).

How much institutional selling is happening at Elevation Oncology?

Institutional investors have sold a total of 3,707,535 shares in the last 24 months. This volume of shares sold represents approximately $8.61M in transactions.


Related Companies:
This page (NASDAQ:ELEV) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Elon to Transform U.S. Economy?
Porter & Company
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts